A STRATEGY FOR DEVELOPING NEW TREATMENT PARADIGMS FOR NEUROPSYCHIATRIC AND NEUROCOGNITIVE SYMPTOMS IN ALZHEIMER'S DISEASE

• Päätekijät: Hugo eGeerts (Tekijä), Athan eSpiros (Tekijä), Patrick eRoberts (Tekijä), Robert eCarr (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: Frontiers Media S.A., 2013-04-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

Successful disease-modifying drug development for Alzheimer's disease has hit a roadblock with the recent failures of amyloid-based therapies, highlighting the translational disconnect between preclinical animal models and clinical outcome. Although disease-modifying therapies are the Holy Grai...